Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trialMichael D. Hill, Cameron McDougall, Dar Dowlatshahi et al.|The Lancet|2020Cited by 623
Endovascular Treatment of Stroke Due to Medium-Vessel OcclusionMayank Goyal, Richard Marigold, Johanna M. Ospel et al.|New England Journal of Medicine|2025Cited by 203
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark Parsons, Vignan Yogendrakumar, Leonid Churilov et al.|The Lancet Neurology|2024Cited by 89
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous ThrombosisThalia S. Field, Kenneth Butcher, Vanessa Dizonno et al.|Stroke|2023Cited by 70
Computed Tomographic Perfusion Predicts Poor Outcomes in a Randomized Trial of Endovascular TherapyRobert Wannamaker, Kenneth Butcher, Taurian Guinand et al.|Stroke|2018Cited by 30